SHAREHOLDER ALERT: GRABAR LAW OFFICE INVESTIGATES INTEGRA LIFESCIENCES HOLDINGS CORPORATION (IART)

Have You Continuously Held Integra LifeSciences Shares Since Prior to March 11, 2019? You May Have Legal Options at No Cost to You.

Philadelphia, Pennsylvania--(Newsfile Corp. - October 14, 2024) - Grabar Law Office is investigating alleged corporate misconduct at Integra LifeSciences Holdings Corporation (NASDAQ: IART). If you have held Integra shares since before March 11, 2019, you may have the right to:

• Demand corporate reforms to improve governance.
• Recover funds spent by company defending class action litigation.
• Receive a court-approved incentive award, all at no cost to you.

Learn more today: https://grabarlaw.com/the-latest/intrga-lifesciences-shareholder-investigation/

Or contact Joshua Grabar at jgrabar@grabarlaw.com or call 267-507-6085 for a free consultation.

What Is the Investigation About?

A recent securities fraud class action complaint alleges the following misconduct by Integra's officers and directors:

1. Misleading statements claiming Integra was on track to expand the market for SurgiMend by securing FDA approval for use in post-mastectomy reconstruction.
2. Artificially inflating stock prices through these misrepresentations.

On May 23, 2023, Integra issued a recall of all products manufactured at its Boston Facility from March 1, 2018, to May 22, 2023. According to the company:

• The Boston Facility failed to meet good manufacturing practices by releasing products with unsafe levels of bacterial endotoxins.
• All production at the Boston Facility was paused, and the company had to revise its second-quarter 2023 guidance, reducing revenue expectations by 6% and adjusted earnings per diluted share by 26%.
• Integra also reported a $22 million impairment charge due to inventory write-offs.

What Can Long-Term Shareholders Do?

If you have continuously held Integra LifeSciences (IART) shares since before March 11, 2019, you may be able to:

• Seek corporate reforms to ensure better governance.
• Recover corporate funds spent on defending litigation.
• Qualify for a court-approved incentive award, at no cost to you.

Take Action Today to Protect Your Rights

Visit: https://grabarlaw.com/the-latest/intrga-lifesciences-shareholder-investigation/.

Or contact Joshua Grabar directly:

• Phone: 267-507-6085
• Email: jgrabar@grabarlaw.com

#IntegraLifeSciences #IART $IART #SecuritiesFraud #ShareholderAlert #InvestorRights #CorporateGovernance #ClassAction #GrabarLaw #FDARecall #StockMarket #LegalAction

Attorney Advertising Disclaimer

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/226580